A Quiet IPO Move with Loud Market Implications
Oura has confidentially submitted paperwork to the US Securities and Exchange Commission for an initial public offering, a strategic step that comes on the heels of a major late-stage fundraise. The smart ring pioneer completed a Series E financing round in October 2025 worth USD 900m (approx. RM4.1bn), putting its valuation at about USD 11bn (approx. RM50.6bn). While the company has not yet disclosed the timing, share count or price range for the IPO, the move positions Oura to ride renewed momentum in technology listings and intensifying competition across wearable health technology. Investment banks including Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co. and Jefferies are reportedly working on the deal, underscoring the perceived strength of the offering. Beyond capital raising, the Oura IPO filing is an important signal that the smart ring market has reached a scale and maturity level that public investors can no longer ignore.
Smart Ring Market Surges as Consumers Seek Discreet Health Tracking
Oura’s rise is tightly linked to changing consumer preferences in health tracking wearables. Many users now want always-on insights without the bulk or visual prominence of a smartwatch, making smart rings an appealing alternative. Oura has built a loyal customer base by focusing on sleep, recovery, stress and cardiovascular metrics through a compact form factor that syncs with both iOS and Android apps. The company has sold 5.5 million rings to date, up sharply from 2.5 million just two years earlier, and disclosed that it expects revenue to grow from USD 500m (approx. RM2.3bn) in 2024 to USD 1.5bn (approx. RM6.9bn) in 2026. Although smart rings still represent a small slice of the overall wearable technology growth story, their rapid adoption suggests that rings are shifting from niche gadget to mainstream health accessory.
From Consumer Gadget to Medtech Platform
While the Oura Ring is officially classified as a consumer wellness product, its ecosystem is increasingly intertwined with the medical device and femtech sectors, strengthening investor confidence in its long-term role in medtech wearables. A USD 75m (approx. RM345m) strategic investment from Dexcom in 2024 paved the way for integrations between Dexcom’s continuous glucose monitoring systems and Oura’s sleep, stress and cardiovascular metrics. This combined data can help users see how factors like poor sleep or certain meals affect glucose variability, blurring the line between lifestyle tracking and clinical insight. A more recent collaboration with Mira extends Oura’s reach into hormone and fertility monitoring, letting ring users access lab-grade hormone testing data. These alliances show how a ring form factor can become a powerful data hub, giving Oura a differentiated position versus general-purpose smartwatches.
IPO Validates Wearable Technology Growth Beyond Smartwatches
Oura’s valuation and IPO ambitions highlight how investor expectations for health tracking wearables have evolved. The company reported more than USD 500m (approx. RM2.3bn) in revenue in 2024, doubling year-on-year, and signalled that it was on track to double again in 2025 and reach USD 1.5bn (approx. RM6.9bn) by 2026. It also expects to surpass five million paid members this quarter, a 4x increase over the past two years, underscoring strong subscription-based engagement. For public markets, this growth profile, combined with recurring revenue, is a compelling story in a category that has traditionally been dominated by smartwatches from Apple and Samsung. Oura’s confidential IPO filing thus serves as a broader validation: investors now view specialised, sensor-rich rings as a durable growth avenue within wearable technology, not just as a passing wellness trend.
What Oura’s Next Chapter Means for the Smart Ring Landscape
The Oura Ring 5 launch, with its fresh design and feature expansion, exemplifies how product innovation is powering the smart ring market forward. As hardware becomes slimmer and sensors more accurate, rings can provide continuous, low-friction monitoring that rivals or even surpasses wrist-worn devices for certain metrics like sleep and recovery. Oura’s push into public markets may catalyse further competition, prompting established tech giants and start-ups alike to invest more heavily in ring-based form factors. For consumers, this should translate into more choice, better accuracy and richer integration between wellness, medical data and everyday devices. For investors, Oura’s IPO is a watershed moment: if the listing performs well, it could unlock capital for a new wave of medtech wearables and cement smart rings as a core pillar of the next-generation digital health ecosystem.